Skip to main content
. 2023 Nov 22;15(23):5525. doi: 10.3390/cancers15235525

Figure 1.

Figure 1

Correlation between Myriad MyChoice and each alternative homologous recombination deficiency (HRD) assay using genomic instability (GI) score. (A) Myriad MyChoice vs. AmoyDx® HRD Focus Panel and (B) Myriad MyChoice vs. OncoScan™.